Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 870 results for "pd"

Baltimore PD release CCTV video in Freddie Gray case, admit me...

20:47 Edited time: April 25, 2015 02:55 A demonstrator holds a sign in front of the Baltimore Police Department Western District station during a protest against the death in police custody of Freddie Gray in Baltimore April 23, 2015. Russia Today, 1 hour ago
New video released in Baltimore PD death Austin American Statesman, 5 hours ago
[x]  

7,694 images for pd

Live 5 WCSC, 6 hours ago
PR Leap, 1 day ago
Live 5 WCSC, 1 day ago
Pittsburgh Post-Gazette, 1 day ago
Pittsburgh Post-Gazette, 1 day ago
Pittsburgh Post-Gazette, 1 day ago
Pittsburgh Post-Gazette, 1 day ago
WAFB, 1 day ago
Rock Hill Herald, 1 day ago
Rock Hill Herald, 1 day ago

PD: 'Most Wanted' woman arrested after 'catch me if you can' post on FB KYW

BRIDGETON, N.J. (CBS) — A woman on Cumberland County's Most Wanted list was arrested after police say she posted a message on Facebook taunting them. Jessica L. Dakins, 30, was listed as the week's Most Wanted in various local newspapers on ...
 CNN1 hour ago

Focused Into Fiber, And New Laser Wavelengths

Bob Struthers with PD-LD gave us a quick rundown of some of their usual products on display at DSS this year and also shared some exciting news in regards to the new laser wavelengths they now offer. He then turned it over to Tom Deberardine so we ...
 Photonics Online1 hour ago

LIVE: Baltimore PD investigation update

Latina DV survivors step out of the shadows Juan Carlos Areán, senior director of the National Latino Network for Healthy Families and Communities, and Christine Jaworsky of Speak Out Against Domestic Violence at the Avon Foundation discuss the ...
 MSNBC8 hours ago

Europe OKs First PD Inhibitor, Nivolumab

Nivolumab ( Opdivo , Bristol-Myers Squibb Company) becomes the first programmed-death (PD) immune checkpoint inhibitor immunotherapy to be recommended for approval in Europe. The European Medicines Agency has recommended approval of the drug for ...
 Diabetes Care10 hours ago Bristol-Myers Squibb Receives Positive CHMP Opinion in the European Union for Opdivo (nivolumab) for the Treatment of Advanced Melanoma in Both First-Line and Previously Treated Patients  Pharmacy Choice9 hours ago CHMP issues positive opinion for Bristol-Myers Squibb's Opdivo in advanced melanoma  FirstWord Pharma13 hours ago European Ad Comm backs Bristol-Myers' Opdivo for melanoma  Seeking Alpha14 hours ago
[x]  

USA: Protesters rally outside Baltimore PD HQ over death of Freddie Gray

Hundreds of people gathered outside the Baltimore Police Department headquarters, Thursday, to protest over the death of Freddie Gray. Twenty-seven-year-old Gray died on Sunday from severe injuries he sustained whilst in police custody. According
 NEWS.com.au20 hours ago Justice Dept. probes Baltimore PD shooting  MSNBC2 days ago US: Two arrested After Scuffles Break Out at Baltimore Protest  Al Intiqad15 hours ago Riots in Baltimore during protests against death of African American detainee  Individual.com18 hours ago

UPDATE 1-Bristol wins EU green light for immune system cancer drug

(Adds detail on PD-1 drugs, other EMA recommendations) LONDON, April 24 (Reuters) - European regulators have recommended approval of Bristol-Myers Squibb's Opdivo, paving the way for it to become the first of a closely watched group of ...
 CNBC16 hours ago REUTERS - UPDATE 1-Bristol wins EU green light for immune system cancer drug  Namibia Press Agency16 hours ago

Yudhoyono to lead Dems for next five years

Susilo Bambang Yudhoyono, Indonesian president from 2004 through 2014, looks set to lead the Democratic Party (PD), which he established in 2003 to win the 2004 presidential election, for the next five years, after he declared his readiness on ...
 Jakarta Post20 hours ago

Celgene will collaborate with Astrazeneca to develop PD-L1 inhibitor program for patients with blood cancers

BOUDRY, Switzerland—Celgene International II Sàrl, a wholly owned subsidiary of Celgene Corporation , has entered into a strategic collaboration with MedImmune Limited , a wholly owned subsidiary of AstraZeneca PLC , to develop and commercialize ...
 Drug Discovery News9 hours ago Celgene Corporation Enters into Strategic Immuno-Oncology Collaboration with AstraZeneca to Develop PD-L1 Inhibitor Program for Patients with Serious Blood Cancers  Minyanville23 hours ago AstraZeneca enters strategic immuno-oncology collaboration with Celgene Corporation to develop PD-L1 inhibitor programme for patients with serious blood cancers  FierceBiotech16 hours ago ASTRAZENECA : enters strategic immuno-oncology collaboration with Celgene Corporation to develop PD-L1 inhibitor programme for patients with serious blood cancers  4 Traders23 hours ago
[x]  

AstraZeneca : Collaboration with Celgene on PD-L1 in haematology

ASTRAZENECA ENTERS STRATEGIC IMMUNO-ONCOLOGY COLLABORATION WITH CELGENE CORPORATION TO DEVELOP PD-L1 INHIBITOR PROGRAMME FOR PATIENTS WITH SERIOUS BLOOD CANCERS AstraZeneca and MedImmune , the Company's global biologics research and development ...
 4 Traders22 hours ago Collaboration with Celgene on PD-L1 in haematology  London Stock Exchange20 hours ago AstraZeneca PLC Collaboration with Celgene on PD-L1 in haematology  ADVFN UK22 hours ago AstraZeneca plc (ADR) (AZN) Q1 Profits Decline Amid Patent Expiry Of Top Drugs  Bidness Etc14 hours ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less